Pfizer Announces Q3 2025 Earnings Call and Performance Report Release
ByAinvest
Tuesday, Sep 23, 2025 10:04 am ET1min read
PFE--
The webcast is scheduled to begin at 8:00 AM EDT and will include a live presentation by Pfizer executives. The transcript and replay of the call will be made available within 24 hours after the live event and will remain accessible for at least 90 days. For those unable to attend the live webcast, the replay will be available on Pfizer's website at www.pfizer.com/investors.
In addition to the Q3 2025 Performance Report, the webcast will provide updates on Pfizer's recent strategic initiatives, including its acquisition of Metsera Inc. (NASDAQ: MTSR). The acquisition, valued at $47.50 per Metsera share in cash, aims to add four highly differentiated clinical-stage incretin and amylin programs to Pfizer's pipeline. The transaction is expected to close in the fourth quarter of 2025, subject to customary closing conditions and regulatory approvals [1].
Investors are encouraged to pre-register for the webcast to avoid operator hold times and to access the necessary information promptly. For more details on the webcast, including how to register, visit Pfizer's investor relations page at www.pfizer.com/investors.
Pfizer invites investors and the public to view a webcast of its conference call with analysts on November 4, 2025. The call will provide an update on Pfizer's Q3 2025 Performance Report, set to be released that morning. The webcast will be available on Pfizer's website, and participants can register in advance to listen to the call. The transcript and replay will be available within 24 hours.
Pfizer Inc. (NYSE: PFE) has announced that it will host a webcast conference call with analysts on November 4, 2025, to provide an update on its Q3 2025 Performance Report. The report is set to be released that morning. Investors and the public are invited to view and listen to the webcast, which will be available on Pfizer's official website. Participants can register in advance to ensure they do not miss the call.The webcast is scheduled to begin at 8:00 AM EDT and will include a live presentation by Pfizer executives. The transcript and replay of the call will be made available within 24 hours after the live event and will remain accessible for at least 90 days. For those unable to attend the live webcast, the replay will be available on Pfizer's website at www.pfizer.com/investors.
In addition to the Q3 2025 Performance Report, the webcast will provide updates on Pfizer's recent strategic initiatives, including its acquisition of Metsera Inc. (NASDAQ: MTSR). The acquisition, valued at $47.50 per Metsera share in cash, aims to add four highly differentiated clinical-stage incretin and amylin programs to Pfizer's pipeline. The transaction is expected to close in the fourth quarter of 2025, subject to customary closing conditions and regulatory approvals [1].
Investors are encouraged to pre-register for the webcast to avoid operator hold times and to access the necessary information promptly. For more details on the webcast, including how to register, visit Pfizer's investor relations page at www.pfizer.com/investors.
Stay ahead of the market.
Get curated U.S. market news, insights and key dates delivered to your inbox.
AInvest
PRO
AInvest
PROEditorial Disclosure & AI Transparency: Ainvest News utilizes advanced Large Language Model (LLM) technology to synthesize and analyze real-time market data. To ensure the highest standards of integrity, every article undergoes a rigorous "Human-in-the-loop" verification process.
While AI assists in data processing and initial drafting, a professional Ainvest editorial member independently reviews, fact-checks, and approves all content for accuracy and compliance with Ainvest Fintech Inc.’s editorial standards. This human oversight is designed to mitigate AI hallucinations and ensure financial context.
Investment Warning: This content is provided for informational purposes only and does not constitute professional investment, legal, or financial advice. Markets involve inherent risks. Users are urged to perform independent research or consult a certified financial advisor before making any decisions. Ainvest Fintech Inc. disclaims all liability for actions taken based on this information. Found an error?Report an Issue
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
Comments
No comments yet